Nanotrap® Virus Particles
2mL of Nanotrap ® Non-Magnetic Virus Particles (10 x 0.2 mL)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Simple and effective capture technology for EVs and exosomes.
Capture of extracellular vesicles and exosomes
Using Ceres Nanosciences’ Nanotrap technology allowed us at ZenBio to rapidly isolate and efficiently concentrate extracellular vesicles and exosomes for our downstream applications. The Ceres team was also consistently responsive and collaborative, which made the capturing process straightforward and simple. We encourage all scientists and researchers to explore Ceres' Nanotrap technology for their own research endeavors.
Review Date: 12 Jun 2020 | Ceres Nanosciences, Inc.
Nanotrap Virus Capture Kit improves the performance of your downstream analytical methods (e.g., PCR, Western blot, NGS, protein assays, infectivity assays) by capturing and concentrating whole virus from complex biological samples.
- Compatible with multiple nucleic acid extraction kits
- Reduce your false negatives by increasing your starting sample volume by more than 10-fold
- Increase your assay sensitivity by capturing and concentrating low abundance viruses
- Nanotrap particles utilize affinity capture and enrichment to attract and bind low abundance viruses
- Nanotrap particles do not utilize antibodies or other biomolecules as affinity molecules
- Nanotrap particles triple the nucleic acid yield as compared to QIAGEN column only
- Incorporating Nanotrap technology into your workflow is simple. No more than 4 steps added to your current workflow or just 7 steps total if you perform the capture, concentration, and extraction with the Ceres Nanosciences platform - compared to an average of 12-plus with the competition.
Rapid SARS-CoV-2 RNA extraction from universal transport medium pooled sample mimics
As demand increases for testing for SARS-CoV-2, technologies that enable pooled testing for the virus will play a critical role in the efforts to remobilize the economy. Recent analyses from public health experts estimate that pooled testing could lower testing costs by up to three-quarters and could increase testing efficiency by as much as 400%, but concerns remain about reduced test sensitivity associated with pooling. Nanotrap® Virus Particles capture and concentrate multiple strains of influenza, RSV, and coronavirus, thus enhancing detection of those viruses, even in co-infection scenarios. Here, we show that Nanotrap® Magnetic Virus Particles can capture and concentrate heat-inactivated SARS-CoV-2 from large volume universal transport medium samples that simulate patient sample pools.
How Nanotrap particles could help COVID-19 monitoring and outbreak containment
University of Connecticut (UConn) microbial ecologist Dr. Kendra Maas reveals how Ceres Nanosciences’ Nanotrap® particles have saved her invaluable time as she builds an ambitious COVID-19 tracking system
Ceres Nanosciences receives $6.5M NIH Award
The award money will help to expand Nanotrap Particle manufacturing capacity for COVID-19 testing
